Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 254 is a processed pseudogene derived from the 5S ribosomal RNA gene family. Pseudogenes are genetic elements that resemble known genes but have lost their ability to produce functional proteins or RNAs due to mutations, deletions, or lack of regulatory sequences. Specifically, rRNA pseudogenes like RNA5SP254 are often the result of retrotransposition events and do not contribute to ribosome structure or function. Unlike functional 5S rRNA, which is essential to the structure and function of the ribosome in all domains of life, pseudogenes such as RNA5SP254 are considered non-functional relics within the genome and do not have known physiological or pathological roles.
None (not a therapeutic target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 254 (RNA5SP254).